Cite
APA Citation
Jackson, C., Choi, J., Zhang, J., Piotrowski, A., Walbert, T., Desai, A., Ahluwalia, M., Nabors, B., Ye, X., Desideri, S., Fisher, J., Wen, P., Grossman, S., Smith, K., Pardoll, D., & Lim, M. (n.d.). iMMU-18. IMMUNOGENOMIC RESPONDER PHENOTYPE FROM A PHASE I TRIAL OF ANTI-LAG3 OR ANTI-CD137 ALONE AND IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH RECURRENT GBM. Neuro-oncology, 21, vi122–vi123. http://access.bl.uk/ark:/81055/vdc_100094879145.0x000054